Global Radiopharmaceutical (Oral Route) Market Growth 2022-2028
- LP 4907322
- 113 Pages
- March 2022
- Pharmaceuticals
The United States Radiopharmaceutical (Oral Route) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Radiopharmaceutical (Oral Route) market, reaching US$ million by the year 2028. As for the Europe Radiopharmaceutical (Oral Route) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Radiopharmaceutical (Oral Route) players cover Bracco Imaging, Bayer, Mallinckrodt, and Nordion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical (Oral Route) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Radiopharmaceutical (Oral Route) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Radiopharmaceutical (Oral Route) by Country/Region, 2017, 2022 & 2028
2.2 Radiopharmaceutical (Oral Route) Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical (Oral Route) Sales by Type
2.3.1 Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2022)
2.3.2 Global Radiopharmaceutical (Oral Route) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Radiopharmaceutical (Oral Route) Sale Price by Type (2017-2022)
2.4 Radiopharmaceutical (Oral Route) Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical (Oral Route) Sales by Application
2.5.1 Global Radiopharmaceutical (Oral Route) Sale Market Share by Application (2017-2022)
2.5.2 Global Radiopharmaceutical (Oral Route) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Radiopharmaceutical (Oral Route) Sale Price by Application (2017-2022)
3 Global Radiopharmaceutical (Oral Route) by Company
3.1 Global Radiopharmaceutical (Oral Route) Breakdown Data by Company
3.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Company (2020-2022)
3.1.2 Global Radiopharmaceutical (Oral Route) Sales Market Share by Company (2020-2022)
3.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Company (2020-2022)
3.2.1 Global Radiopharmaceutical (Oral Route) Revenue by Company (2020-2022)
3.2.2 Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2020-2022)
3.3 Global Radiopharmaceutical (Oral Route) Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical (Oral Route) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical (Oral Route) Product Location Distribution
3.4.2 Players Radiopharmaceutical (Oral Route) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Radiopharmaceutical (Oral Route) by Geographic Region
4.1 World Historic Radiopharmaceutical (Oral Route) Market Size by Geographic Region (2017-2022)
4.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Geographic Region
4.2 World Historic Radiopharmaceutical (Oral Route) Market Size by Country/Region (2017-2022)
4.2.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Country/Region
4.3 Americas Radiopharmaceutical (Oral Route) Sales Growth
4.4 APAC Radiopharmaceutical (Oral Route) Sales Growth
4.5 Europe Radiopharmaceutical (Oral Route) Sales Growth
4.6 Middle East & Africa Radiopharmaceutical (Oral Route) Sales Growth
5 Americas
5.1 Americas Radiopharmaceutical (Oral Route) Sales by Country
5.1.1 Americas Radiopharmaceutical (Oral Route) Sales by Country (2017-2022)
5.1.2 Americas Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022)
5.2 Americas Radiopharmaceutical (Oral Route) Sales by Type
5.3 Americas Radiopharmaceutical (Oral Route) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical (Oral Route) Sales by Region
6.1.1 APAC Radiopharmaceutical (Oral Route) Sales by Region (2017-2022)
6.1.2 APAC Radiopharmaceutical (Oral Route) Revenue by Region (2017-2022)
6.2 APAC Radiopharmaceutical (Oral Route) Sales by Type
6.3 APAC Radiopharmaceutical (Oral Route) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Radiopharmaceutical (Oral Route) by Country
7.1.1 Europe Radiopharmaceutical (Oral Route) Sales by Country (2017-2022)
7.1.2 Europe Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022)
7.2 Europe Radiopharmaceutical (Oral Route) Sales by Type
7.3 Europe Radiopharmaceutical (Oral Route) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceutical (Oral Route) by Country
8.1.1 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022)
8.2 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type
8.3 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical (Oral Route)
10.3 Manufacturing Process Analysis of Radiopharmaceutical (Oral Route)
10.4 Industry Chain Structure of Radiopharmaceutical (Oral Route)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical (Oral Route) Distributors
11.3 Radiopharmaceutical (Oral Route) Customer
12 World Forecast Review for Radiopharmaceutical (Oral Route) by Geographic Region
12.1 Global Radiopharmaceutical (Oral Route) Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical (Oral Route) Forecast by Region (2023-2028)
12.1.2 Global Radiopharmaceutical (Oral Route) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceutical (Oral Route) Forecast by Type
12.7 Global Radiopharmaceutical (Oral Route) Forecast by Application
13 Key Players Analysis
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceutical (Oral Route) Product Offered
13.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Radiopharmaceutical (Oral Route) Product Offered
13.2.3 Bayer Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Radiopharmaceutical (Oral Route) Product Offered
13.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Radiopharmaceutical (Oral Route) Product Offered
13.4.3 Nordion Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Radiopharmaceutical (Oral Route) Product Offered
13.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiopharmaceutical (Oral Route) Product Offered
13.6.3 Lantheus Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 IBA Group
13.7.1 IBA Group Company Information
13.7.2 IBA Group Radiopharmaceutical (Oral Route) Product Offered
13.7.3 IBA Group Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 IBA Group Main Business Overview
13.7.5 IBA Group Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Radiopharmaceutical (Oral Route) Product Offered
13.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 China Isotope & Radiation
13.9.1 China Isotope & Radiation Company Information
13.9.2 China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Offered
13.9.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 China Isotope & Radiation Main Business Overview
13.9.5 China Isotope & Radiation Latest Developments
13.10 Jubilant Pharma
13.10.1 Jubilant Pharma Company Information
13.10.2 Jubilant Pharma Radiopharmaceutical (Oral Route) Product Offered
13.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jubilant Pharma Main Business Overview
13.10.5 Jubilant Pharma Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Radiopharmaceutical (Oral Route) Product Offered
13.11.3 Eli Lilly Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Advanced Accelerator Applications
13.12.1 Advanced Accelerator Applications Company Information
13.12.2 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Offered
13.12.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Advanced Accelerator Applications Main Business Overview
13.12.5 Advanced Accelerator Applications Latest Developments
13.13 SIEMENS
13.13.1 SIEMENS Company Information
13.13.2 SIEMENS Radiopharmaceutical (Oral Route) Product Offered
13.13.3 SIEMENS Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 SIEMENS Main Business Overview
13.13.5 SIEMENS Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical (Oral Route) Product Offered
13.14.3 Dongcheng Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
13.15 Navidea
13.15.1 Navidea Company Information
13.15.2 Navidea Radiopharmaceutical (Oral Route) Product Offered
13.15.3 Navidea Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Navidea Main Business Overview
13.15.5 Navidea Latest Developments
14 Research Findings and Conclusion
Table 1. Radiopharmaceutical (Oral Route) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Radiopharmaceutical (Oral Route) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Radium-223
Table 6. Major Players of Holmium-166
Table 7. Major Players of Other
Table 8. Global Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 9. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2022)
Table 10. Global Radiopharmaceutical (Oral Route) Revenue by Type (2017-2022) & ($ million)
Table 11. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2017-2022)
Table 12. Global Radiopharmaceutical (Oral Route) Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 14. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2022)
Table 15. Global Radiopharmaceutical (Oral Route) Revenue by Application (2017-2022)
Table 16. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application (2017-2022)
Table 17. Global Radiopharmaceutical (Oral Route) Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Radiopharmaceutical (Oral Route) Sales by Company (2020-2022) & (K Units)
Table 19. Global Radiopharmaceutical (Oral Route) Sales Market Share by Company (2020-2022)
Table 20. Global Radiopharmaceutical (Oral Route) Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2020-2022)
Table 22. Global Radiopharmaceutical (Oral Route) Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Radiopharmaceutical (Oral Route) Producing Area Distribution and Sales Area
Table 24. Players Radiopharmaceutical (Oral Route) Products Offered
Table 25. Radiopharmaceutical (Oral Route) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Radiopharmaceutical (Oral Route) Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Radiopharmaceutical (Oral Route) Sales Market Share Geographic Region (2017-2022)
Table 30. Global Radiopharmaceutical (Oral Route) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Radiopharmaceutical (Oral Route) Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Radiopharmaceutical (Oral Route) Sales Market Share by Country/Region (2017-2022)
Table 34. Global Radiopharmaceutical (Oral Route) Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Radiopharmaceutical (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 37. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Country (2017-2022)
Table 38. Americas Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2017-2022)
Table 40. Americas Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 41. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2022)
Table 42. Americas Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 43. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2022)
Table 44. APAC Radiopharmaceutical (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 45. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Region (2017-2022)
Table 46. APAC Radiopharmaceutical (Oral Route) Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Radiopharmaceutical (Oral Route) Revenue Market Share by Region (2017-2022)
Table 48. APAC Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 49. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2022)
Table 50. APAC Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 51. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2022)
Table 52. Europe Radiopharmaceutical (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 53. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country (2017-2022)
Table 54. Europe Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2017-2022)
Table 56. Europe Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 57. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2022)
Table 58. Europe Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 59. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Radiopharmaceutical (Oral Route)
Table 69. Key Market Challenges & Risks of Radiopharmaceutical (Oral Route)
Table 70. Key Industry Trends of Radiopharmaceutical (Oral Route)
Table 71. Radiopharmaceutical (Oral Route) Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Radiopharmaceutical (Oral Route) Distributors List
Table 74. Radiopharmaceutical (Oral Route) Customer List
Table 75. Global Radiopharmaceutical (Oral Route) Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Radiopharmaceutical (Oral Route) Sales Market Forecast by Region
Table 77. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Radiopharmaceutical (Oral Route) Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Radiopharmaceutical (Oral Route) Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Radiopharmaceutical (Oral Route) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Radiopharmaceutical (Oral Route) Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Radiopharmaceutical (Oral Route) Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Radiopharmaceutical (Oral Route) Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Application (2023-2028)
Table 95. Bracco Imaging Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 96. Bracco Imaging Radiopharmaceutical (Oral Route) Product Offered
Table 97. Bracco Imaging Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Bracco Imaging Main Business
Table 99. Bracco Imaging Latest Developments
Table 100. Bayer Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 101. Bayer Radiopharmaceutical (Oral Route) Product Offered
Table 102. Bayer Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Bayer Main Business
Table 104. Bayer Latest Developments
Table 105. Mallinckrodt Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 106. Mallinckrodt Radiopharmaceutical (Oral Route) Product Offered
Table 107. Mallinckrodt Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Mallinckrodt Main Business
Table 109. Mallinckrodt Latest Developments
Table 110. Nordion Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 111. Nordion Radiopharmaceutical (Oral Route) Product Offered
Table 112. Nordion Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Nordion Main Business
Table 114. Nordion Latest Developments
Table 115. Triad Isotopes Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 116. Triad Isotopes Radiopharmaceutical (Oral Route) Product Offered
Table 117. Triad Isotopes Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Triad Isotopes Main Business
Table 119. Triad Isotopes Latest Developments
Table 120. Lantheus Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 121. Lantheus Radiopharmaceutical (Oral Route) Product Offered
Table 122. Lantheus Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Lantheus Main Business
Table 124. Lantheus Latest Developments
Table 125. IBA Group Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 126. IBA Group Radiopharmaceutical (Oral Route) Product Offered
Table 127. IBA Group Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. IBA Group Main Business
Table 129. IBA Group Latest Developments
Table 130. GE Healthcare Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 131. GE Healthcare Radiopharmaceutical (Oral Route) Product Offered
Table 132. GE Healthcare Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. GE Healthcare Main Business
Table 134. GE Healthcare Latest Developments
Table 135. China Isotope & Radiation Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 136. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Offered
Table 137. China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. China Isotope & Radiation Main Business
Table 139. China Isotope & Radiation Latest Developments
Table 140. Jubilant Pharma Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 141. Jubilant Pharma Radiopharmaceutical (Oral Route) Product Offered
Table 142. Jubilant Pharma Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Jubilant Pharma Main Business
Table 144. Jubilant Pharma Latest Developments
Table 145. Eli Lilly Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 146. Eli Lilly Radiopharmaceutical (Oral Route) Product Offered
Table 147. Eli Lilly Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Eli Lilly Main Business
Table 149. Eli Lilly Latest Developments
Table 150. Advanced Accelerator Applications Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 151. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Offered
Table 152. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Advanced Accelerator Applications Main Business
Table 154. Advanced Accelerator Applications Latest Developments
Table 155. SIEMENS Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 156. SIEMENS Radiopharmaceutical (Oral Route) Product Offered
Table 157. SIEMENS Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. SIEMENS Main Business
Table 159. SIEMENS Latest Developments
Table 160. Dongcheng Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 161. Dongcheng Radiopharmaceutical (Oral Route) Product Offered
Table 162. Dongcheng Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. Dongcheng Main Business
Table 164. Dongcheng Latest Developments
Table 165. Navidea Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 166. Navidea Radiopharmaceutical (Oral Route) Product Offered
Table 167. Navidea Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 168. Navidea Main Business
Table 169. Navidea Latest Developments
List of Figures
Figure 1. Picture of Radiopharmaceutical (Oral Route)
Figure 2. Radiopharmaceutical (Oral Route) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical (Oral Route) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Radiopharmaceutical (Oral Route) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Radiopharmaceutical (Oral Route) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Actinium-225
Figure 10. Product Picture of Lutetium-177
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Holmium-166
Figure 13. Product Picture of Other
Figure 14. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type in 2021
Figure 15. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2017-2022)
Figure 16. Radiopharmaceutical (Oral Route) Consumed in Oncology
Figure 17. Global Radiopharmaceutical (Oral Route) Market: Oncology (2017-2022) & (K Units)
Figure 18. Radiopharmaceutical (Oral Route) Consumed in Cardiology
Figure 19. Global Radiopharmaceutical (Oral Route) Market: Cardiology (2017-2022) & (K Units)
Figure 20. Radiopharmaceutical (Oral Route) Consumed in Other
Figure 21. Global Radiopharmaceutical (Oral Route) Market: Other (2017-2022) & (K Units)
Figure 22. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2022)
Figure 23. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application in 2021
Figure 24. Radiopharmaceutical (Oral Route) Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company in 2021
Figure 26. Global Radiopharmaceutical (Oral Route) Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Geographic Region in 2021
Figure 28. Global Radiopharmaceutical (Oral Route) Sales Market Share by Region (2017-2022)
Figure 29. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Country/Region in 2021
Figure 30. Americas Radiopharmaceutical (Oral Route) Sales 2017-2022 (K Units)
Figure 31. Americas Radiopharmaceutical (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 32. APAC Radiopharmaceutical (Oral Route) Sales 2017-2022 (K Units)
Figure 33. APAC Radiopharmaceutical (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 34. Europe Radiopharmaceutical (Oral Route) Sales 2017-2022 (K Units)
Figure 35. Europe Radiopharmaceutical (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Radiopharmaceutical (Oral Route) Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 38. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2021
Figure 39. Americas Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2021
Figure 40. United States Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Region in 2021
Figure 45. APAC Radiopharmaceutical (Oral Route) Revenue Market Share by Regions in 2021
Figure 46. China Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2021
Figure 53. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2021
Figure 54. Germany Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2021
Figure 61. Egypt Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Radiopharmaceutical (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Radiopharmaceutical (Oral Route) in 2021
Figure 67. Manufacturing Process Analysis of Radiopharmaceutical (Oral Route)
Figure 68. Industry Chain Structure of Radiopharmaceutical (Oral Route)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
